AWARDDELIVERY ORDEROther than small business
Delivery order 75F40120F19001CVS HEALTHSPIRE PAYOR & LIFE SCIENCES LLC
Overview
Award facts
- Net obligations
- $1.73M
- $1,725,485of $1.73M potential value
- Outlays (paid to date)
- $424.34K
- $424.34K paid of $1.73M obligated$424,338
- Period of performance
- Sep 30, 2020 to Sep 29, 2021
- Ended
- Modifications
- 3
- Latest action May 26, 2023
- Contract type
- Delivery order
- PIID 75F40120F19001
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS: "BEST 3": HEALTHCARE PATIENT DATA
Dates and value
- Award date
- Signed on Sep 29, 2020
- Potential end of performance
- Sep 28, 2021
- Current value
- $1,725,485Base and exercised options
- Potential value (if all options are exercised)
- $1,725,485
- Parent contract vehicle
- 75F40120D00028 (IDC, multiple award) — 2 orders recorded under it
Obligations by fiscal year of action
- FY2023: -$711,113 (de-obligation)
- FY2021: $825,042
- FY2020: $1,611,556
Total across 3 fiscal years: $1,725,485
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 26, 2023. View on USAspending · Recipient on SAM.gov
Recipient
LocationHARTFORD, CT
UEICNYSJ3KBMW97
CAGE code8N570
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyCVS HEALTH CORPORATION
Business types and certifications
For-profit organizationLimited liability companyCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; Biologics; Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Hartford, Connecticut 06156-0001
- Congressional district (place of performance)
- CT-01As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- B537SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Time and materialsY
- Offers received
- 4
Contract details
- Subcontracting plan
- Individual subcontract planF
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 29, 2020Base obligation at award: $1,611,556
- Latest action
- May 26, 2023 — CloseoutModification P00003; obligation change -$711,113; administrative: no change in scope or value
- Latest substantive action
- Jul 27, 2021 — Supplemental agreement (within scope)Modification P00002; obligation change +$825,042
- Actions by type
- Base award1
- Supplemental agreement (within scope)1
- Closeout1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$711,113
- Latest action: change in base and all options
- -$711,113
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2020/2020-0600-000
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- V: Non-emergency P.L. 117-2
- COVID-19 supplemental obligations
- $312,007
- COVID-19 supplemental outlays
- $312,007